SARS-CoV-2 vaccine program (Avidin)

N/A

Report date: 2025/01/26 17:04:38

Base Information

Drug NameSARS-CoV-2 vaccine program (Avidin)
Drug Alias NameCOVID19 spike glycoprotein modulator (Avidin)protein subunit vaccine (Avidin)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHungary
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvidin Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesAvidin Biotechnology
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A